Genmab A/S (GMAB) News Today $19.32 +0.51 (+2.71%) As of 04/14/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Transactions in Connection with Share Buy-back ProgramApril 14 at 8:42 AM | globenewswire.comRussell Investments Group Ltd. Grows Stake in Genmab A/S (NASDAQ:GMAB)Russell Investments Group Ltd. lifted its stake in Genmab A/S (NASDAQ:GMAB - Free Report) by 18,959.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 510,784 shares of the company's stock after purchasingApril 14 at 4:31 AM | marketbeat.comArrowstreet Capital Limited Partnership Has $635,000 Stock Position in Genmab A/S (NASDAQ:GMAB)Arrowstreet Capital Limited Partnership lessened its holdings in shares of Genmab A/S (NASDAQ:GMAB - Free Report) by 67.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 30,440 shares of the company's stock after selling 63,188 shApril 14 at 3:38 AM | marketbeat.comRenaissance Technologies LLC Has $40.20 Million Stock Holdings in Genmab A/S (NASDAQ:GMAB)Renaissance Technologies LLC increased its stake in Genmab A/S (NASDAQ:GMAB - Free Report) by 7.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,926,150 shares of the company's stock after acquirApril 13 at 5:43 AM | marketbeat.comHC Wainwright Has Strong Forecast for Genmab A/S Q2 EarningsGenmab A/S (NASDAQ:GMAB - Free Report) - Stock analysts at HC Wainwright raised their Q2 2025 earnings per share estimates for Genmab A/S in a research note issued on Wednesday, April 9th. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earnings per share of $0.41 foApril 12 at 8:33 AM | marketbeat.comQ2 Earnings Forecast for Genmab A/S Issued By HC WainwrightApril 12 at 1:57 AM | americanbankingnews.comGenmab A/S's (GMAB) "Buy" Rating Reiterated at HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $37.00 price objective (down previously from $50.00) on shares of Genmab A/S in a research note on Wednesday.April 11, 2025 | marketbeat.comGenmab A/S (NASDAQ:GMAB) Hits New 52-Week Low - Time to Sell?Genmab A/S (NASDAQ:GMAB) Sets New 12-Month Low - What's Next?April 10, 2025 | marketbeat.comGenmab A/S Share Capital ReductionApril 10, 2025 | globenewswire.comGenmab price target lowered to $37 from $50 at H.C. WainwrightApril 9, 2025 | markets.businessinsider.comEmployees Retirement System of Texas Purchases Shares of 78,950 Genmab A/S (NASDAQ:GMAB)Employees Retirement System of Texas acquired a new position in shares of Genmab A/S (NASDAQ:GMAB - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 78,950 shares of the company's stock, valued at approximately $16,477,000. OtheApril 9, 2025 | marketbeat.comSei Investments Co. Buys 20,525 Shares of Genmab A/S (NASDAQ:GMAB)Sei Investments Co. increased its stake in Genmab A/S (NASDAQ:GMAB - Free Report) by 55.2% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 57,702 shares of the company's stock after acquiring an additional 20,525 shares during the period.April 9, 2025 | marketbeat.comTransactions In Connection with Share Buy-back ProgramApril 7, 2025 | globenewswire.comPilgrim Partners Asia Pte Ltd Takes $392,000 Position in Genmab A/S (NASDAQ:GMAB)Pilgrim Partners Asia Pte Ltd acquired a new stake in Genmab A/S (NASDAQ:GMAB - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The fund acquired 18,800 shares of the company's stock, valued at approximately $392,000. Other hedge funds and other institutional iApril 7, 2025 | marketbeat.comGenmab A/S (NASDAQ:GMAB) Shares Purchased by Trexquant Investment LPTrexquant Investment LP increased its stake in shares of Genmab A/S (NASDAQ:GMAB - Free Report) by 495.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 379,936 shares of the company's stock after purchasing an additional 316,089 shares during the periodApril 6, 2025 | marketbeat.comGenmab A/S (NASDAQ:GMAB) Shares Sold by American Century Companies Inc.American Century Companies Inc. lowered its stake in Genmab A/S (NASDAQ:GMAB - Free Report) by 19.3% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 320,575 shares of the company's stock after selling 76,505 shares during the period. American Century Companies IApril 5, 2025 | marketbeat.comOLD Mission Capital LLC Invests $2.33 Million in Genmab A/S (NASDAQ:GMAB)OLD Mission Capital LLC purchased a new position in shares of Genmab A/S (NASDAQ:GMAB - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 111,601 shares of the company's stock, valuedApril 3, 2025 | marketbeat.comStoneX Group Inc. Buys Shares of 66,103 Genmab A/S (NASDAQ:GMAB)StoneX Group Inc. purchased a new position in shares of Genmab A/S (NASDAQ:GMAB - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 66,103 shares of the company's stock, valued at approximately $1,3April 3, 2025 | marketbeat.comGenmab A/S (NASDAQ:GMAB) Sets New 1-Year Low - What's Next?Genmab A/S (NASDAQ:GMAB) Hits New 52-Week Low - Here's What HappenedApril 3, 2025 | marketbeat.comGenmab A/S (NASDAQ:GMAB) Shares Gap Down - Should You Sell?Genmab A/S (NASDAQ:GMAB) Shares Gap Down - Time to Sell?April 2, 2025 | marketbeat.comGenmab downgraded to Underperform from Market Perform at BernsteinApril 2, 2025 | markets.businessinsider.comMorgan Stanley Sticks to Its Hold Rating for Genmab (GMAB)April 2, 2025 | markets.businessinsider.comGenmab A/S (NASDAQ:GMAB) Rating Lowered to "Underperform" at Sanford C. BernsteinSanford C. Bernstein downgraded Genmab A/S from a "market perform" rating to an "underperform" rating in a report on Tuesday.April 2, 2025 | marketbeat.comAlliancebernstein L.P. Sells 200,928 Shares of Genmab A/S (NASDAQ:GMAB)Alliancebernstein L.P. trimmed its stake in Genmab A/S (NASDAQ:GMAB - Free Report) by 1.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 14,935,224 shares of the company's stock after selling 200,928 sharesApril 2, 2025 | marketbeat.comLevel Four Advisory Services LLC Sells 25,668 Shares of Genmab A/S (NASDAQ:GMAB)Level Four Advisory Services LLC reduced its stake in shares of Genmab A/S (NASDAQ:GMAB - Free Report) by 60.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 16,620 shares of the company's stock after selling 2April 2, 2025 | marketbeat.comGenmab A/S (NASDAQ:GMAB) Short Interest Up 32.5% in MarchGenmab A/S (NASDAQ:GMAB - Get Free Report) saw a large growth in short interest in March. As of March 15th, there was short interest totalling 3,060,000 shares, a growth of 32.5% from the February 28th total of 2,310,000 shares. Based on an average daily volume of 1,460,000 shares, the short-interest ratio is currently 2.1 days. Approximately 0.5% of the company's stock are short sold.April 1, 2025 | marketbeat.comTransactions With Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated PersonsApril 1, 2025 | globenewswire.comGenmab drops as Bernstein cuts on Darzalex patent cliffApril 1, 2025 | msn.comIs Genmab A/S (GMAB) the Most Undervalued Healthcare Stock to Buy According to Analysts?April 1, 2025 | msn.comGenmab downgraded by Bernstein amid Darzalex concernsApril 1, 2025 | investing.comGenmab announces EC marketing authorization for TIVDAKMarch 31, 2025 | markets.businessinsider.comTIVDAK® (tisotumab vedotin) Approved by European Commission for Previously Treated Recurrent or Metastatic Cervical CancerMarch 31, 2025 | businesswire.comTransactions in connection with share buy-back programMarch 31, 2025 | globenewswire.comBrandywine Global Investment Management LLC Makes New $33.80 Million Investment in Genmab A/S (NASDAQ:GMAB)Brandywine Global Investment Management LLC acquired a new stake in Genmab A/S (NASDAQ:GMAB - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 1,619,764 shares of the company's stock, valued at approximatelMarch 31, 2025 | marketbeat.comNEOS Investment Management LLC Purchases 37,533 Shares of Genmab A/S (NASDAQ:GMAB)NEOS Investment Management LLC boosted its position in Genmab A/S (NASDAQ:GMAB - Free Report) by 91.2% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 78,683 shares of the company's stock after purchasing an additional 37,533 shares duringMarch 31, 2025 | marketbeat.comRaymond James Financial Inc. Makes New Investment in Genmab A/S (NASDAQ:GMAB)Raymond James Financial Inc. bought a new position in Genmab A/S (NASDAQ:GMAB - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 118,002 shares of the company's stock, valued at approximately $2,463,000. Several other hedge funMarch 30, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Has $1.28 Million Stock Holdings in Genmab A/S (NASDAQ:GMAB)Charles Schwab Investment Management Inc. boosted its position in Genmab A/S (NASDAQ:GMAB - Free Report) by 134.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 61,177 shares of the company's stock after acquirinMarch 30, 2025 | marketbeat.comGenmab A/S (NASDAQ:GMAB) Receives Consensus Recommendation of "Moderate Buy" from AnalystsGenmab A/S (NASDAQ:GMAB - Get Free Report) has received an average recommendation of "Moderate Buy" from the thirteen research firms that are covering the firm, Marketbeat.com reports. Four research analysts have rated the stock with a hold recommendation, eight have issued a buy recommendation anMarch 30, 2025 | marketbeat.comGenmab Announces Approval Of TIVDAK In Japan - Quick FactsMarch 29, 2025 | nasdaq.comGenmab announces Tivdak approval in JapanMarch 28, 2025 | markets.businessinsider.comJapanese Drug Regulator Approves Genmab Cancer Drug For Patients With Advanced Cervical CancerMarch 27, 2025 | benzinga.comGenmab launches share buy-back programMarch 27, 2025 | uk.investing.comGenmab A/S (NASDAQ:GMAB) Shares Gap Up - Time to Buy?Genmab A/S (NASDAQ:GMAB) Shares Gap Up - Here's WhyMarch 27, 2025 | marketbeat.comTIVDAK® (tisotumab vedotin) Approved by Japan Ministry of Health, Labour and Welfare for the Treatment of Advanced or Recurrent Cervical Cancer that has Progressed on or after ChemotherapyMarch 27, 2025 | businesswire.comGenmab Announces Initiation of Share Buy-Back ProgramMarch 25, 2025 | globenewswire.comGenmab A/S (NASDAQ:GMAB) Shares Gap Down - Time to Sell?Genmab A/S (NASDAQ:GMAB) Shares Gap Down - Should You Sell?March 25, 2025 | marketbeat.comGenmab stock falls amid AbbVie lawsuitMarch 24, 2025 | investing.comMadison Investment Advisors LLC Takes Position in Genmab A/S (NASDAQ:GMAB)Madison Investment Advisors LLC purchased a new stake in shares of Genmab A/S (NASDAQ:GMAB - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 46,904 shares of the company's stock, valued at apprMarch 23, 2025 | marketbeat.comSignaturefd LLC Increases Position in Genmab A/S (NASDAQ:GMAB)Signaturefd LLC increased its stake in Genmab A/S (NASDAQ:GMAB - Free Report) by 163.2% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 20,790 shares of the company's stock after acquiring an additional 12,890 shares during the period. SigMarch 22, 2025 | marketbeat.comGenmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc.March 21, 2025 | globenewswire.com Remove Ads Get Genmab A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for GMAB and its competitors with MarketBeat's FREE daily newsletter. Email Address GMAB Media Mentions By Week GMAB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GMAB News Sentiment▼0.820.80▲Average Medical News Sentiment GMAB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GMAB Articles This Week▼186▲GMAB Articles Average Week Remove Ads Get Genmab A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for GMAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Takeda Pharmaceutical News Today argenx News Today Beigene News Today BioNTech News Today Teva Pharmaceutical Industries News Today Intra-Cellular Therapies News Today Summit Therapeutics News Today Dr. Reddy's Laboratories News Today Moderna News Today Viatris News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GMAB) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genmab A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Genmab A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GMAB Stock Free GMAB Stock Alerts